Chronic Pulmonary Obstructive Disease (COPD) On High Resolution Computed Tomography: COPD on High Resolution Computed Tomography

Shahraz  Ashraf; Ali  Junaid Dar; Urwa  Nasir

doi:10.54393/pbmj.v6i3.852

Authors

Shahraz Ashraf University Institute of Radiological Sciences and Medical Imaging Technology, The University of Lahore, Gujrat, Pakistan
Ali Junaid Dar University Institute of Radiological Sciences and Medical Imaging Technology, The University of Lahore, Gujrat, Pakistan
Urwa Nasir University Institute of Radiological Sciences and Medical Imaging Technology, The University of Lahore, Gujrat, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v6i3.852

Keywords:

COPD, HRCT, Walk Test, FEVI, FVC

Abstract

The prevalent, preventable, and treatable chronic lung illness known as chronic obstructive pulmonary disease (COPD), which may be accurately detected on HRCT, affects both men and women worldwide. Objective: To evaluate the diagnostic features of chronic pulmonary obstructive disease (COPD) using high resolution computed tomography. Methods: This study included 120 patients with COPD at least having a comprehensive clinical record of 6MWT defined as COPD by a post-bronchodilator FEV1/FVC 70% with sustained expiratory flow limitation. The sample size was computed at 120 patients using convenient approach and non-contrast HRCT was performed using 64 slides scanning from the apex of the lung to the diaphragm. Emphysema scoring and -950 HU criteria were used to automatically partition the lungs without including the central airways. The data were entered and analyzed on SPSS version 22. Results: HRCT scan findings show that patients with parenchymal bands were 9(7.5%) with bronchial wall thickening, nodules were (24)20%, bronchiectasis were (23)19%, apical fibrosis were (19)15%, and tree on bud pattern were (12)10%. Conclusions: It is concluded that COPD is common in males and worsens in cigarette or tobacco smokers, with a prevalence of parenchymal bands, bronchial wall thickening, nodules, bronchiectasis, apical fibrosis, and tree-on-bud patterns.

References

Laniado-Laborín R. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21st century. International Journal of Environmental Research and Public Health. 2009 Jan; 6(1): 209-24. doi: 10.3390/ijerph6010209

Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. The Lancet. 2004 Aug; 364(9435): 709-21. doi: 10.1016/S0140-6736(04)16900-6

Aoshiba K and Nagai A. Differences in airway remodeling between asthma and chronic obstructive pulmonary disease. Clinical Reviews in Allergy & Immunology. 2004 Aug; 27: 35-43. doi: 10.1385/CRIAI:27:1:035

Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. 1998 Feb; 53(2): 129. doi: 10.1136/thx.53.2.129

Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine. 2017 Sep; 5(9): 691-706.

Boschetto P, Quintavalle S, Miotto D, Lo Cascio N, Zeni E, Mapp CE. Chronic obstructive pulmonary disease (COPD) and occupational exposures. Journal of Occupational Medicine and Toxicology. 2006 Dec; 1: 1-6. doi: 10.1186/1745-6673-1-11

Petrescu F, Voican SC, Silosi I. Tumor necrosis factor-α serum levels in healthy smokers and nonsmokers. International Journal of Chronic Obstructive Pulmonary Disease. 2010 Aug: 217-22. doi: 10.2147/COPD.S8330

Eklund BM, Nilsson S, Hedman L, Lindberg I. Why do smokers diagnosed with COPD not quit smoking?-a qualitative study. Tobacco Induced Diseases. 2012 Dec; 10(1): 1-7. doi: 10.1186/1617-9625-10-17

Yang X, Zhang T, Zhang Y, Chen H, Sang S. Global burden of COPD attributable to ambient PM2. 5 in 204 countries and territories, 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Science of the Total Environment. 2021 Nov; 796: 148819. doi: 10.1016/j.scitotenv.2021.148819

Siddharthan T, Wosu AC, Pollard SL, Hossen S, Alupo P, Shade T, et al. A novel case-finding instrument for chronic obstructive pulmonary disease in low-and middle-income country settings. International Journal of Chronic Obstructive Pulmonary Disease. 2020 Nov: 2769-77. doi: 10.2147/COPD.S268076

Bozkus F, Dikmen N, Samur A. Microalbuminuria in subjects with COPD: relationship to the new version of global initiative for chronic obstructive lung disease staging. Respiratory Care. 2017 Mar; 62(3): 307-14. doi: 10.4187/respcare.05168

Bartholmai BJ, Raghunath S, Karwoski RA, Moua T, Rajagopalan S, Maldonado F, et al. Quantitative CT imaging of interstitial lung diseases. Journal of Thoracic Imaging. 2013 Sep; 28(5). doi: 10.1097/RTI.0b013e3182a21969

Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. International Journal of Chronic Obstructive Pulmonary Disease. 2012 Apr: 283-9. doi: 10.2147/COPD.S30651

Adeloye D, Basquill C, Papana A, Chan KY, Rudan I, Campbell H. An estimate of the prevalence of COPD in Africa: a systematic analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2015 Jan; 12(1): 71-81. doi: 10.3109/15412555.2014.908834

López‐Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016 Jan; 21(1): 14-23. doi: 10.1111/resp.12660

Lohne V, Heer HC, Andersen M, Miaskowski C, Kongerud J, Rustøen T. Qualitative study of pain of patients with chronic obstructive pulmonary disease. Heart & Lung. 2010 May; 39(3): 226-34. doi: 10.1016/j.hrtlng.2009.08.002

Brandsma CA, Van den Berge M, Hackett TL, Brusselle G, Timens W. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. The Journal of Pathology. 2020 Apr; 250(5): 624-35. doi: 10.1002/path.5364

Salvi S. Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease. Clinics in Chest Medicine. 2014 Mar; 35(1): 17-27. doi: 10.1016/j.ccm.2013.09.011

Jögi J, Ekberg M, Jonson B, Bozovic G, Bajc M. Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT. European Journal of Nuclear Medicine and Molecular Imaging. 2011 Jul; 38: 1344-52. doi: 10.1007/s00259-011-1757-5

Grydeland TB, Dirksen A, Coxson HO, Eagan TM, Thorsen E, Pillai SG, et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. American Journal of Respiratory and Critical Care Medicine. 2010 Feb; 181(4): 353-9. doi: 10.1164/rccm.200907-1008OC

Politis A, Ioannidis V, Gourgoulianis KI, Daniil Z, Hatzoglou C. Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial. Chronic Respiratory Disease. 2018 May; 15(2): 146-56. doi: 10.1177/1479972317740128

Diaz-Guzman E and Mannino DM. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clinics in Chest Medicine. 2014 Mar; 35(1): 7-16. doi: 10.1016/j.ccm.2013.10.002

Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. European Respiratory Journal. 2001 May; 17(5): 982-94. doi: 10.1183/09031936.01.17509820

Kesimer M, Ford AA, Ceppe A, Radicioni G, Cao R, Davis CW, et al. Airway mucin concentration as a marker of chronic bronchitis. New England Journal of Medicine. 2017 Sep; 377(10): 911-22. doi: 10.1056/NEJMoa1701632

Ntritsos G, Franek J, Belbasis L, Christou MA, Markozannes G, Altman P, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease. 2018 May: 1507-14. doi: 10.2147/COPD.S146390

Barnes PJ. Sex differences in chronic obstructive pulmonary disease mechanisms. American journal of respiratory and critical care medicine. 2016 Apr; 193(8):813-4. doi: 10.2147/COPD.S146390

Kojima S, Sakakibara H, Motani S, Hirose K, Mizuno F, Ochiai M, et al. Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population. Journal of epidemiology. 2007; 17(2): 54-60. doi: 10.2188/jea.17.54

Chen J, Yin Y, Zhang Y, Lin X, Chen T, Yang Z, et al. Chronic Obstructive Pulmonary Disease Prevalence and Associated Risk Factors in Adults Aged 40 Years and Older in Southeast China: A Cross-Sectional Study During 2019–2020. International Journal of Chronic Obstructive Pulmonary Disease. 2022 Jan: 2317-28. doi: 10.2147/COPD.S377857

Gutiérrez F, Masiá M, Mirete C, Soldán B, Rodríguez JC, Padilla S, et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. Journal of infection. 2006 Sep; 53(3): 166-74. doi: 10.1016/j.jinf.2005.11.006

Moreira MA, Barbosa MA, Queiroz MC, Teixeira KI, Santana Júnior PJ, Montadon Júnior ME, Jardim JR. Pulmonary changes on HRCT scans in nonsmoking females with COPD due to wood smoke exposure. Jornal Brasileiro de pneumologia. 2013 Mar; 39: 155-63. doi: 10.1590/S1806-37132013000200006